CL2012003210A1 - Metodo para producir aceite que comprende por lo menos un pufa que comprende recuperar aceite a partir de la planta brassica, un descendiente, célula, tejido, semilla o parte de la misma, genéticamente modificada; composicion de aceite a partir de semillas de una planta brassica. - Google Patents

Metodo para producir aceite que comprende por lo menos un pufa que comprende recuperar aceite a partir de la planta brassica, un descendiente, célula, tejido, semilla o parte de la misma, genéticamente modificada; composicion de aceite a partir de semillas de una planta brassica.

Info

Publication number
CL2012003210A1
CL2012003210A1 CL2012003210A CL2012003210A CL2012003210A1 CL 2012003210 A1 CL2012003210 A1 CL 2012003210A1 CL 2012003210 A CL2012003210 A CL 2012003210A CL 2012003210 A CL2012003210 A CL 2012003210A CL 2012003210 A1 CL2012003210 A1 CL 2012003210A1
Authority
CL
Chile
Prior art keywords
oil
brassica plant
pufa
descendant
seeds
Prior art date
Application number
CL2012003210A
Other languages
English (en)
Inventor
Ann Owens Merlo
Daniel Gachotte
Paul Gordon Roessler
Scott Bedan
Jerry M Kuner
James G Metz
Terence A Walsh
Original Assignee
Dow Agrosciences Llc
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc, Dsm Ip Assets Bv filed Critical Dow Agrosciences Llc
Publication of CL2012003210A1 publication Critical patent/CL2012003210A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6432Eicosapentaenoic acids [EPA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6434Docosahexenoic acids [DHA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1288Transferases for other substituted phosphate groups (2.7.8)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
CL2012003210A 2010-05-17 2012-11-16 Metodo para producir aceite que comprende por lo menos un pufa que comprende recuperar aceite a partir de la planta brassica, un descendiente, célula, tejido, semilla o parte de la misma, genéticamente modificada; composicion de aceite a partir de semillas de una planta brassica. CL2012003210A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34553710P 2010-05-17 2010-05-17

Publications (1)

Publication Number Publication Date
CL2012003210A1 true CL2012003210A1 (es) 2013-08-02

Family

ID=44992026

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003210A CL2012003210A1 (es) 2010-05-17 2012-11-16 Metodo para producir aceite que comprende por lo menos un pufa que comprende recuperar aceite a partir de la planta brassica, un descendiente, célula, tejido, semilla o parte de la misma, genéticamente modificada; composicion de aceite a partir de semillas de una planta brassica.

Country Status (25)

Country Link
US (5) US20130150599A1 (es)
EP (3) EP3517617A1 (es)
JP (1) JP6059138B2 (es)
KR (1) KR102184432B1 (es)
CN (2) CN103080319B (es)
AR (1) AR081201A1 (es)
AU (1) AU2011256209B2 (es)
BR (1) BR112012029255A2 (es)
CA (2) CA2799559C (es)
CL (1) CL2012003210A1 (es)
EA (1) EA201291223A1 (es)
ES (1) ES2656217T3 (es)
HU (1) HUE036182T2 (es)
IL (1) IL223045A0 (es)
MX (1) MX345243B (es)
MY (1) MY165098A (es)
NO (1) NO2571994T3 (es)
NZ (1) NZ604479A (es)
PH (1) PH12012502267A1 (es)
PL (1) PL2571994T3 (es)
PT (1) PT2571994T (es)
SG (1) SG185572A1 (es)
TW (1) TW201144442A (es)
UA (1) UA116613C2 (es)
WO (1) WO2011146524A1 (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11236351B2 (en) * 2010-05-17 2022-02-01 Dow Agrosciences Llc Production of DHA and other LC PUFAs in plants
TW201144442A (en) * 2010-05-17 2011-12-16 Dow Agrosciences Llc Production of DHA and other LC-PUFAs in plants
WO2012091651A1 (en) * 2010-12-30 2012-07-05 Telefonaktiebolaget L M Ericsson (Publ) Methods and apparatuses for enabling power back-off indication in phr in a telecommunications system
TW201307553A (zh) * 2011-07-26 2013-02-16 Dow Agrosciences Llc 在植物中生產二十二碳六烯酸(dha)及其他長鏈多元不飽和脂肪酸(lc-pufa)之技術
CN109468241A (zh) 2011-10-19 2019-03-15 麻省理工学院 工程改造的微生物及用于微生物油生产的方法
KR102214275B1 (ko) 2011-12-30 2021-02-09 다우 아그로사이언시즈 엘엘씨 카놀라 가공 동안의 dha 유지
BR122019026149A8 (pt) 2012-06-15 2022-06-28 Commw Scient Ind Res Org Célula hospedeira, processo de produzir um lipídio de planta extraído, método de produzir semente, farinha de semente, método para produzir um produto alimentício, uso e processo para produzir ésteres de etila
AR091774A1 (es) * 2012-07-16 2015-02-25 Dow Agrosciences Llc Proceso para el diseño de las secuencias de adn repetidas, largas, divergentes de codones optimizados
WO2014043053A1 (en) * 2012-09-11 2014-03-20 Dow Agrosciences Llc Omega-9 canola oil blended with dha
WO2014152986A2 (en) * 2013-03-15 2014-09-25 Hollister Lisa Genetically modified plants that are herbivore-resistant
WO2014144147A2 (en) 2013-03-15 2014-09-18 HOLLISTER, Lisa Genetically modified plants that are insect-resistant and/or rot-resistant
KR20160065952A (ko) 2013-10-04 2016-06-09 다우 아그로사이언시즈 엘엘씨 제아 메이스 메탈로티오네인-유사 조절 요소 및 그의 용도
BR102014025574A2 (pt) 2013-10-15 2015-09-29 Dow Agrosciences Llc elementos regulatórios de zea mays e usos dos mesmos
BR102014025499A2 (pt) 2013-10-15 2015-09-29 Dow Agrosciences Llc elementos regulatórios de zea mays e uso dos mesmos
TW201525136A (zh) * 2013-11-26 2015-07-01 Dow Agrosciences Llc 利用破囊壺菌PUFA合成酶於油籽作物中生成ω-3長鏈多不飽和脂肪酸
PE20170253A1 (es) 2013-12-18 2017-04-14 Nuseed Pty Ltd Lipido que comprende acidos grasos poliinsaturados de cadena larga
TW201527313A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子(二)
TW201527316A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子(五)
TW201527312A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子(一)
TW201527314A (zh) 2013-12-31 2015-07-16 Dow Agrosciences Llc 新穎玉米泛素啓動子(三)
BR102015000943A2 (pt) 2014-01-17 2016-06-07 Dow Agrosciences Llc expressão aumentada de proteína em planta
US10087430B2 (en) 2014-01-28 2018-10-02 Dsm Ip Assets B.V. Factors for the production and accumulation of polyunsaturated fatty acids (PUFAS) derived from PUFA synthases
TW201538518A (zh) 2014-02-28 2015-10-16 Dow Agrosciences Llc 藉由嵌合基因調控元件所賦予之根部特異性表現
AU2015281791A1 (en) 2014-06-27 2017-01-12 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
WO2016075327A2 (en) 2014-11-14 2016-05-19 Basf Plant Science Company Gmbh Production of pufas in plants
BR112017021703B1 (pt) 2015-04-15 2023-11-28 Corteva Agriscience Llc Promotor de planta para expressão de transgene
EP3283633A2 (en) 2015-04-15 2018-02-21 Dow AgroSciences LLC Plant promoter for transgene expression
TW201718862A (zh) 2015-09-22 2017-06-01 Dow Agrosciences Llc 用於轉殖基因表現之植物啟動子及3’utr
TW201718861A (zh) 2015-09-22 2017-06-01 道禮責任有限公司 用於轉殖基因表現之植物啟動子及3’utr
CN108473997B (zh) 2015-10-22 2022-04-12 美国陶氏益农公司 用于转基因表达的植物启动子
US20170121726A1 (en) 2015-11-04 2017-05-04 Dow Agrosciences Llc Plant promoter for transgene expression
JP6966040B2 (ja) 2016-05-12 2021-11-10 ディーエスエム アイピー アセッツ ビー.ブイ.Dsm Ip Assets B.V. 微細藻類中でのオメガ−3多価不飽和脂肪酸産生を増加させる方法
IL263731B2 (en) * 2016-06-16 2023-03-01 Nuseed Pty Ltd Canola ns-b50027-4
US10400246B2 (en) 2016-10-03 2019-09-03 Dow Agrosciences Llc Plant promoter for transgene expression
WO2018067265A1 (en) 2016-10-03 2018-04-12 Dow Agrosciences Llc Plant promoter for transgene expression
CN111278276B (zh) 2017-06-28 2023-05-26 美国陶氏益农公司 用于转基因表达的植物启动子
CA3073050A1 (en) 2017-08-31 2019-03-07 Dow Agrosciences Llc Compositions and methods for expressing transgenes using regulatory elements from chlorophyll binding ab genes
US11225670B2 (en) 2017-10-30 2022-01-18 Corteva Agriscience Llc Plant promoter for transgene expression
US12241101B2 (en) 2018-08-10 2025-03-04 Kyowa Hakko Bio Co., Ltd. Microorganism producing polyunsaturated fatty acid and method for producing polyunsaturated fatty acid
JP7838921B2 (ja) 2018-08-10 2026-04-01 協和発酵バイオ株式会社 エイコサペンタエン酸を生産する微生物及びエイコサペンタエン酸の製造法
CN109852724A (zh) * 2019-04-03 2019-06-07 深圳出入境检验检疫局食品检验检疫技术中心 转基因油菜品系oxy235检测方法、试剂和试剂盒
EP4430063A1 (en) 2021-11-09 2024-09-18 Benson Hill, Inc. Promoter elements for improved polynucleotide expression in plants
WO2023111961A1 (en) 2021-12-15 2023-06-22 Benson Hill, Inc. Spatio-temporal promoters for polynucleotide expression in plants
US20240035100A1 (en) * 2022-06-27 2024-02-01 Monsanto Technology Llc Soybean transgenic event gm_csm63770 and methods for detection and uses thereof
WO2024127362A1 (en) 2022-12-15 2024-06-20 Benson Hill, Inc. Spatio-temporal promoters for polynucleotide expression in plants
WO2025238190A1 (en) 2024-05-15 2025-11-20 Dsm Ip Assets B.V. Spray-dried powders having high pufa content

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8300698A (nl) 1983-02-24 1984-09-17 Univ Leiden Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
US5420034A (en) 1986-07-31 1995-05-30 Calgene, Inc. Seed-specific transcriptional regulation
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5693507A (en) 1988-09-26 1997-12-02 Auburn University Genetic engineering of plant chloroplasts
US5451513A (en) 1990-05-01 1995-09-19 The State University of New Jersey Rutgers Method for stably transforming plastids of multicellular plants
ATE202144T1 (de) 1991-04-09 2001-06-15 Unilever Nv Pflanzen-promoter involviert in der kontrolle der lipid-biosynthese in samen
US6210700B1 (en) 1997-01-14 2001-04-03 Novartis Nutrition Ag Enhancement of transplant graft survival through nutritional immunomodulation with omega-9 fatty acid dietary supplement therapy
US6140486A (en) 1997-06-04 2000-10-31 Calgene Llc Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants
US6566583B1 (en) * 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
DE69941009D1 (de) * 1998-11-17 2009-07-30 Monsanto Technology Llc Phosphonat metabolisierende pflanzen
US7217856B2 (en) 1999-01-14 2007-05-15 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US7247461B2 (en) 1999-01-14 2007-07-24 Martek Biosciences Corporation Nucleic acid molecule encoding ORFA of a PUFA polyketide synthase system and uses thereof
US8003772B2 (en) 1999-01-14 2011-08-23 Martek Biosciences Corporation Chimeric PUFA polyketide synthase systems and uses thereof
US7211418B2 (en) 1999-01-14 2007-05-01 Martek Biosciences Corporation PUFA polyketide synthase systems and uses thereof
US6784342B1 (en) 1999-08-04 2004-08-31 The University Of British Columbia Regulation of embryonic transcription in plants
KR100785946B1 (ko) 1999-09-30 2007-12-14 니뽄 다바코 산교 가부시키가이샤 식물 형질전환 벡터
WO2001090386A2 (en) 2000-05-24 2001-11-29 The University Of British Columbia Gene regulatory region that promotes early seed-specific transcription
WO2001090364A2 (en) * 2000-05-24 2001-11-29 The University Of British Columbia Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme
US20040172682A1 (en) 2003-02-12 2004-09-02 Kinney Anthony J. Production of very long chain polyunsaturated fatty acids in oilseed plants
DE602005021675D1 (de) * 2004-11-04 2010-07-15 Monsanto Technology Llc Verfahren zur herstellung von ölzusammensetzungen
WO2006135866A2 (en) 2005-06-10 2006-12-21 Martek Biosciences Corporation Pufa polyketide synthase systems and uses thereof
CN101262760A (zh) * 2005-08-01 2008-09-10 加拿大农业和农业食品部 包含高油酸、低亚麻酸油的低纤维黄色油菜种子
US7868228B2 (en) 2006-01-31 2011-01-11 Monsanto Technology Llc Phosphopantetheinyl transferases from bacteria
KR101524398B1 (ko) * 2006-03-15 2015-06-04 디에스엠 아이피 어셋츠 비.브이. Pufa 폴리케티드 신타제 시스템을 이용한 이종 생물체내 다불포화 지방산의 제조
VN24011A1 (en) * 2006-08-29 2010-10-25 Martek Biosciences Corp Use of DPA(n-6) oils in infant formula
WO2009085169A2 (en) 2007-12-21 2009-07-09 National Research Council Of Canada Diacylglycerol acyltransferase 2 genes and proteins encoded thereby from algae
JP2011519552A (ja) * 2008-04-25 2011-07-14 ビーエーエスエフ プラント サイエンス ゲーエムベーハー 植物種子油
JP5757870B2 (ja) * 2008-08-26 2015-08-05 ビーエーエスエフ プラント サイエンス ゲーエムベーハー デサチュラーゼをコードする核酸および改変植物油
CN102741267B (zh) * 2009-03-19 2020-06-23 帝斯曼知识产权资产有限公司 多不饱和脂肪酸合酶核酸分子和多肽,及其组合物、制备方法和用途
TW201144442A (en) * 2010-05-17 2011-12-16 Dow Agrosciences Llc Production of DHA and other LC-PUFAs in plants

Also Published As

Publication number Publication date
CN105296511A (zh) 2016-02-03
UA116613C2 (uk) 2018-04-25
US20200362361A1 (en) 2020-11-19
US11168332B2 (en) 2021-11-09
MY165098A (en) 2018-02-28
JP2013529086A (ja) 2013-07-18
MX345243B (es) 2017-01-23
PL2571994T3 (pl) 2018-06-29
KR102184432B1 (ko) 2020-12-01
CA2799559C (en) 2022-06-28
US20220170037A1 (en) 2022-06-02
AR081201A1 (es) 2012-07-04
CA3161375A1 (en) 2011-11-24
NZ604479A (en) 2014-10-31
US20130150599A1 (en) 2013-06-13
HUE036182T2 (hu) 2018-06-28
US10669554B2 (en) 2020-06-02
IL223045A0 (en) 2013-02-03
PT2571994T (pt) 2018-03-14
BR112012029255A2 (pt) 2015-09-08
CN103080319A (zh) 2013-05-01
EP3517617A1 (en) 2019-07-31
AU2011256209B2 (en) 2016-12-22
US12006504B2 (en) 2024-06-11
SG185572A1 (en) 2012-12-28
WO2011146524A1 (en) 2011-11-24
EP3354739A1 (en) 2018-08-01
US20180073036A1 (en) 2018-03-15
CN103080319B (zh) 2015-11-25
AU2011256209A1 (en) 2013-01-10
KR20130109974A (ko) 2013-10-08
MX2012013401A (es) 2013-09-02
US20190010510A1 (en) 2019-01-10
HK1179652A1 (zh) 2013-10-04
EP2571994A4 (en) 2013-10-23
EP2571994B1 (en) 2017-12-13
EP2571994A1 (en) 2013-03-27
PH12012502267A1 (en) 2013-02-11
TW201144442A (en) 2011-12-16
JP6059138B2 (ja) 2017-01-11
EA201291223A1 (ru) 2013-05-30
NO2571994T3 (es) 2018-05-12
CA2799559A1 (en) 2011-11-24
ES2656217T3 (es) 2018-02-26

Similar Documents

Publication Publication Date Title
BRPI0815822A2 (pt) lignina e outros produtos a partir de material de planta, e métodos e composições para estes.
BRPI0810233A2 (pt) Defensina de planta quimérica, método para produzir uma planta transgênica, planta transgênica, parte, progenia ou semente, métodos para reduzir um efeito tóxico de expressão de defensina em uma planta transgênica, e par aumentar a resistência a fingos em ma variedade de planta, e em uma variedade de algodão.
CL2012002419A1 (es) Metodo para mejorar una caracteristica de una planta que comprende administrar bacillus subtilis fb17 a la planta, semilla o al suelo alrededor de la planta o semilla; y metodo para producir biocombustible.
BRPI0814244A2 (pt) Método para obtenção de uma planta geneticamente engenheirada
CL2013000803A1 (es) Metodo para incrementar la velocidad de germinacion de una semilla mediado por dmo (divisional de la solicitud 835-09).
CL2013000425A1 (es) Metodo para la preparacion de lignina a partir de material lignocelulosico por produccion de pulpa con alcohol, agua y una base, a una temperatura menor de 100°c.
CL2014001715A1 (es) Proceso para producir lípidos a partir de la parte vegetativa de una planta u organismos transgénicos con un nivel aumentado de lípidos no-polares, particularmente triacilgliceroles; planta; organismo transgénico; célula; proceso de obtención de la célula.
BRPI0806960A2 (pt) Molécula de dsrna, coleção de moléculas de dsrna, planta transgência, e, método para preparar uma planta transgênica.
CL2012003413A1 (es) Metodo para aumentar la tolerancia al estres medioambiental abiotico de una planta; metodo para mejorar calidad y/o rendimiento y/o el vigor de un cultivo vegetal; metodo para reducir los daños en una planta provocados por uno o mas factores de estres medioambiental abiotico, que comprenden la aplicacion de al menos un ciclopropeno en el agua de irrigación de la planta.
BRPI0808266A2 (pt) semente, planta e célula de uma planta de lactuva sativa híbrida, populações de sementes de lactuva sativa híbrida, uso de insetos e processo de obtenção de sementes lactuva sativa híbridas
CL2014001026A1 (es) Metodos para producir planta que contiene propiedades alteradas de lignina (divisional de la solicitud 985-2011).
BRPI0819551A2 (pt) "semente de diversos milhos de phjep designando, planta produzida a partir da semente ou semente de progenitura, célula vegetal da planta, processo para identificação de uma primeira planta de milho verde e semente de milho verde"
CL2013001572A1 (es) Celula de planta de soja que comprende el evento pdab8264.44.06.1; metodo para el control de malezas; metodo de produccion de una planta de soja transgenica; y metodo de identificacion de dicho evento.
CL2011000502A1 (es) Composicion que comprende al menos una bacteria formadora de esporas, al menos un agente para combatir insectos y un disolvente; y procedimiento proteger una semilla, parte vegetal o planta geneticamente modificada de nematodos basado en la aplicacion de la composicion descrita anteriormente.
CL2012001800A1 (es) Método para incrementar la producción de cultivos, que comprende administrar a una planta de cultivo una composicion que comprende 95% de 9-beta-d-adenosina; composicion que comprende dicho compuesto y un fertilizante.
BRPI0815843A2 (pt) Método para recuperar petróleo a partir de um poço de petróleo.
BRPI0806951A2 (pt) MOLÉCULA DE dsRNA, COLEÇÃO DE MOLÉCULAS DE dsRNA, PLANTA TRANSGÊNICA, E, MÉTODO DE PREPARAR UMA PLANTA TRANSGÊNICA.
ES2388927T8 (es) Extracto natural que contiene xantohumol, así como el procedimiento para su producción y productos obtenidos a partir del mismo
BR112013000237A2 (pt) método para a preparação de 1,3-propanodiol a partir de sacarose
JP2011525472A5 (es)
CL2014000163A1 (es) Procedimiento de obtencion de una composicion que contiene factores de crecimiento a partir de plaquetas; composición que compre de factores de crecimiento.
CL2008001253A1 (es) Metodo para la obtencion de una planta brassica oleracea resistente al albugo candida.
BRPI0621384A2 (pt) Agente de tratamento agronômico, processo para obter agente de tratamento agronômico, material de planta, processo de tratamento agronômico
BRPI0917371A2 (pt) planta trangênica transformada com um vetor de expressão, semente, vetor de expressão, e, método para produzir uma planta trangênica resistente a nematóides.
CL2008000685A1 (es) Metodo para la produccion de una celula vegetal o planta con ascorbato aumentado que comprende transformar con un polinucleotido con actividad gdp-l-galactosa guaniltransferasa; polinucleotido que codifica dicha actividad.